Associate, Pureos Bioventures
Ximing joined the Pureos Bioventures team in 2018. Prior to Pureos, he was Post-Doc at the European Molecular Biology Laboratory in Heidelberg, Germany. Ximing is currently BoD observer at Araris Biotech, Engimmune Therapeutics and Tridek-One. Ximing obtained his PhD at the European Molecular Biology Laboratory and holds an MSc. in Biology at ETH Zurich.